High-tech cancer drugs send PBS costs soaring Oct 10, 2009
The cost of treating each patient for the bone marrow disease multiple myeloma with thalidomide derivative Revlimid is expected average about $6500 a month, which means it is likely to become Australia's most expensive publicly-funded cancer drug. People could expect, on average, an 11-month extension of reasonable quality life, said the acting Health Minister, Justine Elliot, announcing the decision to fund the drug via the Pharmaceutical Benefits Scheme. (Sydney Morning Herald -- Australia)
Gene found for new therapies for bone marrow disease Sep 30, 2009
Gene that could lead to new therapies for bone marrow disease identified - Science - NEWS - The Times of India ... Gene that could lead to new therapies for bone marrow disease identified ... WASHINGTON: Scientists from Van Andel Research Institute (VARI) have identified a gene that helps in progression of Myelodysplastic Syndrome (MDS), a bone marrow disease. (India Times, India)
Health calendar Sep 11, 2009
THIRD ANNUAL HAWAI'I MYELOMA COMMUNITY WORKSHOP, with information on the bone marrow disease, treatment options at diagnosis or relapse, side effects and clinical trials; with expert speakers, including Dr. Robert Vesio, director, Myeloma Program, Cedars Sinai Cancer Center; free; 10 a.m.-2 p.m. Sept. 11, The Queen's Medical Center, Conference Center (room 203); free; open to the public; registration, 800-452-2873, or. ROLE OF MEDITATION IN THE MODERN WORLD' LECTURE, "Mindfulness and the... (Honolulu Advertiser)
Multiple Types Of White Blood Cells Made Directly From Embryonic And Adult Stem Cells Aug 14, 2009
If the adult cells came from people with certain bone marrow diseases, the new technique could produce blood cells with specific defects. It could also be used to grow specific varieties of immune cells that could target specific infections or tumors. (Science Daily)
Suspected Nazi's lawyer seeks to end trial Aug 7, 2009
He said Demjanjuk (dem-YAHN'-yuk) suffers from Myelodysplastic syndrome, a bone marrow disease, and could only have months to live. He estimated that the trial could last two to four years, given the restrictions on sessions' length, the complexity of the evidence, and the fact that testimony will have to be translated into five languages to accommodate seven or eight people who have joined on as co-prosecutors as allowed under German law. (MSNBC -- International)
Demjanjuk faces 27,900 counts in trial Jul 14, 2009
The younger Demjanjuk said his father has an incurable leukemic bone marrow disease. However, doctors earlier this month determined that Demjanjuk was fit to stand trial so long as court hearings do not exceed two 90-minute sessions per day. (Boston Globe)
Prosecutors: Demjanjuk fit for trial Jul 4, 2009
His son, John Demjanjuk Jr. told The Associated Press in an e-mail that German doctors have determined his father has about 16 months to live, due to his incurable leukemic bone marrow disease. "With less than (two) years for my father to live, a career-seeking German prosecutor is hastily pressing forward indicative of a 100 percent politically motivated effort to blame Ukrainians and Europeans for the crimes of the Germans," Demjanjuk Jr. wrote. (MSNBC -- International)
Alleged Nazi guard called fit for trial Jul 4, 2009
But his son, John Demjanjuk Jr., vowed to vigorously dispute the doctors decision, saying they have given him only 16 months to live due to an incurable leukemic bone marrow disease. This has nothing to do with bringing anyone to justice or fitness for trial. (Boston Globe)
A Common Genetic Mechanism in Malignant Bone Marrow Diseases May 28, 2009
Volume 360:2355-2357. Ross L. Levine, M.D., and Martin Carroll, M.D.. (New England Journal of Medicine)
Alleged Nazi in German prison on charges May 13, 2009
Demjanjuk's son, John Demjanjuk Jr., said Monday his father is dying of leukemic bone marrow disease and claimed he would not survive a trans-Atlantic flight. Video. (MSNBC -- International)
Now in Germany, Demjanjuk may soon be charged May 13, 2009
Demjanjuk's son, John Demjanjuk Jr., said Monday his father is dying of leukemic bone marrow disease and said he would not survive a trans-Atlantic flight. Dramatic photos last month showed Demjanjuk wincing in apparent pain as he was removed by immigration agents from his home in Seven Hills, Ohio, during an attempt to deport him. (Boston Globe)
Demjanjuk's health a key issue for any trial May 12, 2009
Demjanjuk's son, John Demjanjuk Jr., said Monday that his father is dying of leukemic bone marrow disease and may not even survive the flight from Cleveland to Munich. Timing is everything in the case, according to Jonathan Drimmer, who served as the lead lawyer in the 2002 U.S. case against Demjanjuk. (WSVN-TV Miami, FL)
Nazi guard suspect arrives in Germany May 12, 2009
Demjanjuk's son, John Demjanjuk Jr., said Monday that his father is dying of leukemic bone marrow disease. "It is not a question if he is sick but how sick he is, there are enough diagnoses confirming his illness, the only question is how fast his sickness is progressing," Maull told AP Television News. (Huntington WSAZ-TV, WV)
Top US justice denies bid to block ex-Nazi's extradition May 8, 2009
Demjanjuk suffers from a host of health problems, including kidney disease, bone marrow disease, arthritis and severe back pain. His family and lawyer have argued that the long flight to Germany and subsequent imprisonment and trial would cause pain tantamount to torture. (Yahoo News -- Politics)
Antisoma plc reports half-year results for the six months to 31 ... Feb 16, 2009
This form of leukaemia follows previous bone marrow disease or treatment for other cancers, and has a poor prognosis and poor responsiveness to currently available treatments. During the period, we agreed with the FDA an enlargement of the phase III trial, such that it will now enrol around 450 patients. (CNNMoney.com)
